Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
The older drugs were found to be less effective for treating obesity and came with significant safety issues
To compete with the upcoming generics, Novo Nordisk received Health Canada approval on December 22, 2025, for two new branded products, Plosbrio and Poviztra
Here's how they stack up The Quick Take: Both supplements speak to the GLP-1 conversation, but only one was actually formulated around it
Most patients experience only 24-48 hours of downtime
It now stands out as a strong antioxidant, countering the free radicals inside the body
US$ 27.28
US$ 25.18
US$ 26.69
US$ 29.56
US$ 27.64
US$ 23.11
US$ 26.80
US$ 25.69
US$ 25.49
US$ 26.48
US$ 25.36
US$ 25.41
